Exchange: NASDAQ·Updated 03:59 PM EDT
SGMO logo

SGMO Sangamo Therapeutics Inc

$0.161
$0.0052
(3.13%)
Today
Reported EarningsMay 14
Mkt Cap$66.7M
Vol1.3M

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The firm focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
19

Extremely Bearish Sentiment

How do you feel about SGMO?

Advertisement|Remove ads.